Funding Changes the Game Funding is often treated like a turning point. More capital, more visibility, more opportunity. On paper, it should make growth easier. In reality, it usually does the opposite. What worked to get early traction—founder-led selling, flexible messaging, and opportunistic deals—rarely holds up under the pressure that follows funding. Expectations shift quickly. Pipeline needs to become predictable. Revenue needs to follow a clearer path. And as more sta

Boston, MA — February 11, 2026 Bostonia Growth Partners today announced the launch of the Bostonia Diagnostic™ , a commercialization intelligence solution designed to help venture-backed health tech companies identify what’s slowing growth — and what to do next. As healthcare innovation accelerates, many companies reach a critical inflection point: strong products, early traction, and successful pilots — but no clear path to scalable, repeatable revenue. Bostonia was built to

Founder-Led Sales Works—Until It Doesn’t In the early stages, growth is driven by the founder. Deals happen through relationships. Messaging is flexible. Opportunities are pursued as they come. Speed matters more than structure. And it works. Early traction builds. Pilots close. Momentum starts to form. But what works early doesn’t hold as the company begins to scale. Why Growth Starts to Slow At a certain point, growth begins to feel less predictable. Some deals move forward